Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2006-04-18 | Directors (other than directors who are full-time employees of the Company, who do not receive directors' fees) are entitled to receive an annual retainer of $12,000 payable in cash in monthly installments of $1,000. On July 1, 2005, each then non-employee director received an option for 3,750 shares of Common Stock at an exercise price of $15.20 per share, the fair market value on the date of grant. The options were fully exercisable on the date of grant and have a term of ten years. Payment of the exercise price of the options may be in cash or in previously-acquired shares of Common Stock. In December 2005, vesting was accelerated for stock options covering 3,938 shares for each non-employee director other than Mr. Justesen, who held no unvested options. |
| 2007-04-17 | The current members of the Audit Committee are Messrs. Carley (chair), Hicks, Johnson, and Meeker. The current members of the Compensation Committee are Messrs. Meeker (chair), Hicks, and Justesen. The current members of the Nominating Committee are Messrs. Hicks (chair), Carley, Justesen, and Meeker. |
| 2008-04-14 | The Audit Committee members include Messrs. Carley (chair), Hicks, Johnson, and Meeker. The Compensation Committee members are Messrs. Meeker (chair), Hicks, and Justesen. The Nominating Committee members include Messrs. Hicks (chair), Carley, Justesen, and Meeker. Director compensation table shows James B. Hicks received $18,000 total in 2007. |
| 2009-04-10 | The Audit Committee members include Messrs. Carley (chair), Hicks, Johnson, and Meeker. The Compensation Committee members are Messrs. Meeker (chair), Hicks, and Justesen. The Nominating Committee members are Messrs. Hicks (chair), Carley, Justesen, and Meeker. Director compensation table shows James B. Hicks, Ph.D. received $24,950 in total compensation for 2008. |
| 2010-04-05 | The current members of the Audit Committee are Messrs. Carley (chair), Hicks, Johnson, and Meeker. The Compensation Committee current members are Messrs. Meeker (chair), Hicks, and Justesen. The Nominating Committee current members are Messrs. Hicks (chair), Carley, Justesen, and Meeker. The following table summarizes compensation paid to the Companys directors (other than Mr. Sherertz) for services during 2009. James B. Hicks, Ph.D.: $34,218 total compensation. |
| 2011-04-18 | Dr. Hicks is chair of the Compensation Committee and Nominating Committee, and member of the Audit Committee. Director compensation table shows James B. Hicks total compensation of $35,937. |
| 2012-04-26 | Dr. Hicks is chair of the Board's Compensation and Nominating Committees. The Compensation Committee members include Dr. Hicks (chair) and Messrs. Carley and Justesen. The Nominating Committee members include Messrs. Hicks (chair), Carley, Johnson, Justesen, and Meeker. The Audit Committee members include Messrs. Carley (chair), Hicks, Johnson, and Meeker. Director compensation table shows James B. Hicks received $71,839 in total compensation in 2011. |
| 2013-04-19 | The current members of the Compensation Committee are Dr. Hicks (chair) and Messrs. Carley, Justesen, and Meeker. The current members of the Audit Committee are Messrs. Carley (chair), Hicks, Johnson, and Meeker. The following table summarizes compensation paid to the Companys outside directors for services during 2012. James B. Hicks, Ph.D.: $105,600 total compensation. |
| 2014-04-22 | Dr. Hicks provides valuable business and financial insight to the Board. He is chair of the Board's Compensation Committee. |
| 2015-04-22 | Dr. Hicks is chair of the Board's Compensation Committee. The Audit Committee members include Messrs. Carley (chair), Hicks and Johnson. Director compensation table shows James B. Hicks total compensation of $121,208. |
| 2016-06-01 | James B. Hicks is Research Professor ... Dr. Hicks provides valuable business and financial insight to the Board. He is chair of the Board’s Compensation Committee. ... The current members of the Audit Committee are Messrs. Meeker (chair), Hicks and Johnson. ... Director compensation table shows total compensation of $121,237 for 2015. |
| 2017-04-28 | Through his experience with other public companies, Dr. Hicks provides valuable business and financial insight to the Board. He is chair of the Board’s Compensation Committee. |
| 2018-04-27 | James B. Hicks, Ph.D., has been Professor of Research in Biological Sciences at the University of Southern California since 2014... He is chair of the Board’s Compensation Committee... The following table summarizes compensation paid to the Company’s outside directors for services during 2017... James B. Hicks, Ph.D.... Total $136,508. |
| 2019-04-24 | Dr. Hicks is chair of the Board’s Compensation Committee and member of Audit and Compliance Committee. Director compensation table shows total compensation of $139,981 for 2018. |
| 2020-04-24 | James B. Hicks, Ph.D., has been Professor of Research in Biological Sciences at the University of Southern California since 2014. From 2004 until 2016, Dr. Hicks was Professor of Biomedical Research at Cold Spring Harbor Laboratory in New York. He is a co-founder and director of Virogenomics, Inc., a private biotechnology company located in the Portland, Oregon metropolitan area, for which he previously served as Chief Technology Officer. Dr. Hicks was a director of AVI BioPharma, Inc. (now Sarepta Therapeutics, Inc.), from 1997 until October 2007 and a member of AVI BioPharma, Inc.’s audit committee and chair of its compensation committee. Between 1990 and 2006, Dr. Hicks co-founded five biotech or internet companies. He completed a postdoctoral program at Cornell University, received a Ph.D. from the University of Oregon, and received a B.A. degree from Willamette University. Through his experience with other public companies, Dr. Hicks provides valuable business and financial insight to the Board. |
| 2021-04-23 | Dr. Hicks serves on the Audit and Compliance Committee and the Compensation Committee. Director compensation table shows total compensation of $147,463. |
Data sourced from SEC filings. Last updated: 2026-02-03